Literature DB >> 8427771

Proliferative behaviour of an oestrogen sensitive rat mammary tumour: evidence for a paracrine interaction between tumour and stroma.

M G Ormerod1, J C Titley, T A Smith, A L Tombs, S Eccles.   

Abstract

An oestrogen-sensitive rat mammary tumour (OES HR1) has been grown in normal female rats and in female and male rats supplemented with oestrone. In some rats, after the tumour was established, both exogenous and endogenous sources of oestrogen were removed--a treatment which inhibited further growth of the tumour. The proliferative characteristics of the tumours were measured by injecting the rats with deoxybromouridine (BrdU) 4 h before removing the tumour. Extracted nuclei were reacted with anti-BrdU and the labelling index and DNA content measured by flow cytometry. A correlation between the number of (diploid) host cells present and the number of (aneuploid) tumour cells in S-phase of the cell cycle was observed. This result suggests that there are paracrine interactions between tumour and host cells. We also observed that, on oestrogen ablation, the labelling index was significantly reduced while the percentage of cells in S-phase changed far less. The demonstration that there are cells in S-phase which are not proliferating highlights a possible problem with the measurement of proliferation in human tumours from a DNA histogram.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8427771      PMCID: PMC1968219          DOI: 10.1038/bjc.1993.18

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

1.  Characterization of estrogen responsive transforming activity in human breast cancer cell lines.

Authors:  R B Dickson; S E Bates; M E McManaway; M E Lippman
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

Review 2.  Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma.

Authors:  R B Dickson; M E Lippman
Journal:  Endocr Rev       Date:  1987-02       Impact factor: 19.871

3.  A method to measure the duration of DNA synthesis and the potential doubling time from a single sample.

Authors:  A C Begg; N J McNally; D C Shrieve; H Kärcher
Journal:  Cytometry       Date:  1985-11

4.  8th San Antonio Breast Cancer Symposium--Plenary lecture. Autocrine and paracrine growth regulation of human breast cancer.

Authors:  M E Lippman; R B Dickson; S Bates; C Knabbe; K Huff; S Swain; M McManaway; D Bronzert; A Kasid; E P Gelmann
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

5.  The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry.

Authors:  G D Wilson; N J McNally; E Dunphy; H Kärcher; R Pfragner
Journal:  Cytometry       Date:  1985-11

6.  Mitogenicity of human fibroblasts in vivo for human breast cancer cells.

Authors:  K Horgan; D L Jones; R E Mansel
Journal:  Br J Surg       Date:  1987-03       Impact factor: 6.939

7.  Identification of a chemoattractant for fibroblasts produced by human breast carcinoma cell lines.

Authors:  W E Gleiber; E Schiffmann
Journal:  Cancer Res       Date:  1984-08       Impact factor: 12.701

8.  Production of PDGF-like growth factor by breast cancer cell lines.

Authors:  E Rozengurt; J Sinnett-Smith; J Taylor-Papadimitriou
Journal:  Int J Cancer       Date:  1985-08-15       Impact factor: 7.396

9.  Hormonal control of immunoreactive somatomedin production by cultured human fibroblasts.

Authors:  D R Clemmons; L E Underwood; J J Van Wyk
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

10.  Stromal influences on breast cancer cell growth.

Authors:  C E van Roozendaal; B van Ooijen; J G Klijn; C Claassen; A M Eggermont; S C Henzen-Logmans; J A Foekens
Journal:  Br J Cancer       Date:  1992-01       Impact factor: 7.640

View more
  3 in total

Review 1.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part III. Proliferation in normal, injured and diseased tissue, growth factors, differentiation, DNA replication sites and in situ hybridization.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1996-08

Review 2.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part II: Oncology, chemotherapy and carcinogenesis.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1995-12

Review 3.  Preclinical models for the evaluation of targeted therapies of metastatic disease.

Authors:  S A Eccles; G Box; W Court; J Sandle; C J Dean
Journal:  Cell Biophys       Date:  1994
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.